Exhaled nitric oxide and asthma control: A longitudinal study in unselected patients

European Respiratory Journal

Volumn 31, Issue 3, 2008, Pages 539-546

  Michils, A ^a   Baldassarre, S ^a   Van Muylem, A ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b Chest Dept   (Belgium)

Author keywords

Asthma control; Exhaled nitric oxide; Lung function

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID DERIVATIVE; NITRIC OXIDE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DETERIORATION; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT SELECTION; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; BIOASSAY; EXHALATION; FEMALE; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE; ROC CURVE; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOLOGICAL MARKERS; BRONCHODILATOR AGENTS; ENDPOINT DETERMINATION; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NITRIC OXIDE; REFERENCE VALUES; ROC CURVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 42949087512     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00020407     Document Type: Article

References (30)

1. Global initiative for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. Washington, DC, U.S. Government Printing Office, 2002. NHLBI Publication 02-3659.
2. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721.
3. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159: 1043-1051.
4. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370.
5. Crater SE, Peters EJ, Martin ML, Andrew WM, Platts-Mills TAE. Expired nitric oxide and airway obstruction in asthma patients with an acute exacerbation. Am Resp Crit Care Med 1999; 158: 806-811.
6. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153: 454-457.
7. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164: 738-743.
8. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163-2173.
9. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management. Am J Respir Crit Care Med 2007; 176: 231-237.
10. Travers J, Marsh S, Williams M, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 2007; 62: 219-223.
11. Taylor RD, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006; 61: 817-827.
12. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907.
13. McSharry CP, McKay IC, Chaudhuri R, Livingston E, Fraser I, Thomson NC. Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma. J Allergy Clin Immunol 2005; 116: 88-93.
14. Juniper EF, Bousquet J, Abetz L, Bateman ED, the GOAL Committee. Identifying "well-controlled" and "not well controlled" asthma using the asthma control questionnaire. Respir Med 2006; 73: 296-305.
15. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999; 54: 108-114.
16. Jones SL, Herbison P, Cowan JO, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002; 20: 601-608.
17. Wenzel S. Severe asthma in adults. Am J Resp Crit Care Med 2005; 172: 149-160.
18. Juniper EF, Svensson K, Mörk AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99: 553-558.
19. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
20. European Respiratory Society. Standardized lung function testing: lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: Suppl. 16, 5-40.
21. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35.
22. SennaG, Passalacqua G, Chiapoli M, Lombardi C, Wilcock L. Correlation among FEV1, nitric oxide and asthma control test in newly diagnosed asthma. Allergy 2007; 62: 207.
23. Lopes C. FeNO 35ppb - is it associated with asthma control? J Allergy Clin Immunol 2006; 117: Suppl. 2, S177.
24. Teeter J, Bleecker E. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998; 113: 272-277.
25. Jatakanon A, Lim S, Barnes P. Changes in sputum eosinophils predict loss of asthma control. Am J Resp Crit Care Med 2000; 161: 64-72.
26. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163: 406-412.
27. Silkoff PE, Lent AM, Busacker AA, et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005; 116: 1249-1255.
28. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115: 233-242.
29. Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005; 172: 453-459.
30. Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006; 129: 1492-1499.